SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-037063
Filing Date
2023-10-12
Accepted
2023-10-12 16:58:43
Documents
12
Period of Report
2023-10-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39955
  Complete submission text file 0001493152-23-037063.txt   206254

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE atrx-20231012.xsd EX-101.SCH 3024
3 XBRL LABEL FILE atrx-20231012_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE atrx-20231012_pre.xml EX-101.PRE 22365
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 2936
Mailing Address P.O. BOX 2161 WAKE FOREST NC 27588
Business Address P.O. BOX 2161 WAKE FOREST NC 27588 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-13789 | Film No.: 231323268
SIC: 2834 Pharmaceutical Preparations